21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Keto creamy carbonated beverage formulations
#8402METHODS AND MEANS FOR EFFICIENT DKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-MRNA
#8403PH20 polypeptide variants, formulations and uses thereof
#8404ANTI-CD6 ANTIBODY COMPOSITIONS AND METHODS FOR TREATING AND REDUCING NEGATIVE EFFECTS OF A CORONAVIRUS INCLUDING COVID-19
#8405METHODS AND COMPOSITIONS TO ENHANCE HUMORAL IMMUNITY TO REDUCE CYTOMEGALOVIRUS INFECTION AND REACTIVATION BY IL-6 INHIBITION
#8406Method of Selecting Patients for Treatment with a Combination of an AXL Inhibitor and an Immune Checkpoint Modulator
#8407COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS
#8408METHODS OF TREATING IMMUNE MEDIATED PULMONARY INJURY
#8409CD229 Car T Cells And Methods Of Use Thereof
#8410Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets
#8411NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#8412PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#8413Compounds Useful in HIV Therapy
#8414GPR40 AGONISTS
#8415BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
#8416IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF
#8417B-LACTAM COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
#8418NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRAL INFECTIONS AND RESPIRATORY COMPLICATIONS, IN PARTICULAR CAUSED BY INFLUENZAVIRUS OR CORONAVIRUS
#8419N-HETEROARYLALKYL-2-(HETEROCYCLYL AND HETEROCYCLYLMETHYL) ACETAMIDE DERIVATIVES AS SSTR4 AGONISTS
#8420COMPOSITIONS AND METHODS OF USING CYANINE DYES TO TARGET CANCER AND MITOCHONDRIA
#8421Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
#8422USP9X inhibitors
#8423GAS-CONTAINING SURFACE COVER, ARRANGEMENT, AND USE
#8424Delivery device and formulation
#8425REDUCED CALORIC INTAKE AND IMMUNOTHERAPY FOR THE TREATMENT OF CANCER
#8426USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING MONOCYTE IMMUNE RESPONSE
#8427IMMUNOGENIC TREATMENT OF CANCER
#8428METHODS OF TREATING VIRAL INFECTIONS USING ARGINASE
#8429COMPOSITIONS AND METHODS FOR DISRUPTING BIOFILM FORMATION AND MAINTENANCE
#8430TREATMENT OF ALT CANCERS
#8431CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#8432SMAC mimetic
#8433Composition for the treatment and/or prevention of lower urinary tract symptoms
#8434MODULATION OF NCRNAS, LYMPHOCYTES, NEUTROPHILS, INFLAMMASOMES AND P53
#8435ENGINEERED ONCOLYTIC ADENOVIRUS
#8436COMPOSITIONS AND METHODS COMPRISING CLOSTRIDIUM BUTYRICUM FOR THE TREATMENT OF CANCER
#8437COMPOSITIONS AND TREATMENTS FOR ISCHEMIC INJURIES
#8438IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR TARGETING CANCER FIBROBLASTS
#8439LONG LIVED T CELLS FOR TREATING HIV INFECTION
#8440USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF MUSCLE, LIGAMENT OR TENDON PAIN INDUCED BY PHYSICAL ACTIVITY AND CORRESPONDING COMPOSITIONS
#8441NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#8442COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTION-INDUCED CARDIOMYOPATHY
#8443COMPOSITIONS COMPRISING COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE WITH TROMETHAMINE AND METHODS OF USE
#8444COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS, 17-HDHA AND 18-HEPE AND METHODS OF USING SAME
#8445COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS, 17-HDHA AND 18-HEPE AND METHODS OF USING SAME
#8446METHODS AND COMPOSITIONS FOR TREATING CANCER
#8447COMPOUNDS AND USES THEREOF
#8448HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY
#8449TREATMENT OF CONDITIONS ASSOCIATED WITH THYROID HORMONE
#8450TREATMENT OF HUMAN PAPILLOMAVIRUS-ASSOCIATED CANCERS BY PD-L1 INHIBITORS
#8451Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation
#8452METHODS AND COMPOSITIONSFOR TREATING VIRAL INFECTIONS
#8453TREATMENT OF CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES
#8454Combination Therapy with AXL Inhibitor and Immune Checkpoint Modulator or Oncolytic Virus
#8455METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING AND PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH VIRAL INFECTIONS
#8456COMBINATION THERAPY FOR ACUTE MYELOID LEUKEMIA
#8457PHARMACEUTICAL METHODS
#8458METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS
#8459Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome
#8460METHODS OF TREATING CORONAVIRUS INFECTIONS USING ANGIOTENSIN-CONVERTING ENZYME 2 INHIBITORS
#8461ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS
#8462THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE
#8463TREATMENT OF SYMPTOMATIC VIRAL DISEASES
#8464LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER
#8465Analogs of cyclobenzaprine and amitryptilene
#8466METHODS OF TREATMENT OF CORONAVIRUS-INDUCED INFLAMMATION CONDITIONS
#8467BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS
#8468Compositions And Methods For Treating Feeding Tube Patients
#8469OPHTHALMIC FORMULATION AND ITS USE
#8470FORMULATIONS FOR PROMOTING HYDRATION AND METHODS OF USE THEREOF
#8471Use of Salmeterol as an Anti-Coronaviral Agent
#8472Hexylamine salts and methods of using hexylamine
#8473COMPOSITIONS COMPRISING THYMOL AND AMINO ACIDS FOR USE IN THE TREATMENT OF INFLAMMATORY OR FUNCTIONAL INTESTINAL DISORDERS
#8474EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF DISEASE
#8475INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO
#8476Injectable and inhalable formulations
#8477CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE
#8478Products having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
#8479BENZOTHIAZOLE DERIVATIVES AND 7-AZA-BENZOTHIAZOLE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF
#8480PULMONARY FIBROSIS MEDICINE CONTAINING PYRAZOLE DERIVATIVE
#8481VACCINE ADJUVANTS
#8482COMPOSITIONS OF STABLE FORMULATIONS OF VARENICLINE SALT OR BASE FORM WITH CONTROL ON NITROSO IMPURITIES
#8483SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION
#8484SMALL MOLECULE INHIBITORS OF SARS-CoV-2 VIRAL REPLICATION AND USES THEREOF
#8485JELLYFISH COLLAGEN USE
#8486METHODS OF TREATING SYSTEMIC SCLEROSIS
#8487CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONIST
#8488ARYLAMIDES AND METHODS OF USE THEREOF
#8489TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND RELATED CONDITIONS WITH ANTAGONISTS OF E-SELECTIN
#8490Treatment of Chemosensory Dysfunction from a Coronavirus Infection
#8491CXCR5 Antagonists and Methods of Treating Diseases or Disorders Using Same
#8492ENHANCEMENT OF ANTI-TUMOR ACTIVITY OF SHP2 INHIBITOR PYRIMIDINONE IN COMBINATION WITH NOVEL CANCER MEDICINES IN CANCERS
#8493Anti-MERTK agonistic antibodies and uses thereof
#8494METHOD FOR TREATMENT AND PROPHYLAXIS OF CRS IN PATIENTS COMPRISING A COMBINATION OF BISPECIFIC ANTIBODIES BINDING TO CDS X CANCER CELL AND TNF ALPHA OR IL-6 INHIBITOR
#8495COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR
#8496Treatment of respiratory diseases
#8497Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors
#8498Lysophosphatidic acid derivative
#8499BCMA BINDING MOLECULES AND METHODS OF USE THEREOF
#8500SMALL MOLECULES INDUCING THE DEGRADATION OF THE CELLULAR PRION PROTEIN
#8501ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
#8502Non-hormonal compositions and methods for male contraception
#8503USE OF FAK INHIBITOR IN PREPARATION OF DRUG FOR TREATING TUMORS HAVING NRAS MUTATION
#8504PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES AND METHODS OF USE
#8505COMPOSITIONS AND METHODS OF TREATING CANCER
#8506Use of amisulpride as an anti-emetic
#8507MODULATORS OF THE INTEGRATED STRESS PATHWAY
#8508ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF
#8509Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
#8510Stable ascorbic acid compositions and methods of using same
#8511COMPOSITION AND METHODS FOR IMPROVING THICKNESS AND RECEPTIVITY OF ENDOMETRIAL LINING
#8512TAFOXIPARIN FOR THE TREATMENT OF PREECLAMPSIA
#8513Article for use with an apparatus for heating an aerosol generating agent
#8514TREATMENT OF OSTEOGENESIS IMPERFECTA
#8515IMMUNE EFFECTOR CELL IN WHICH EXPRESSION IS REGULATED BY CYTOKINES
#8516Cancer therapy
#8517SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME
#8518METHOD AND DRUG FOR TREATING PARKINSON'S DISEASE
#8519PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES
#8520ANTI-PD-L1 ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#8521BACTERIUM OF THE CHRISTENSENELLACEAE FAMILY AND COMPOSITION CONTAINING SAME FOR PREVENTING AND/OR TREATING RENAL INSUFFICIENCY
#8522PROTEIN-PROTEIN INTERACTION STABILIZERS
#8523Ketone inhibitors of lysine gingipain
#8524COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
#8525METHOD OF TREATING CANCER OR A BLOOD DISORDER
#8526Pharmaceutical compositions and methods
#8527GENE CLASSIFIERS AND USES THEREOF IN SKIN CANCERS
#8528METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES
#8529COMPOSITIONS AND METHODS FOR THE TREATMENT OF PERVASIVE DEVELOPMENT DISORDERS
#8530Almitrine for treating the hypoxemia of a coronavirus infection
#8531COENZYME Q10 FORMULATIONS IN THE TREATMENT AND PREVENTION OF EPIDERMOLYSIS BULLOSA
#8532PEROXIREDOXIN 6 OR A SYNTHETIC ANALOGUE THEREOF FOR USE AS A HYPOGLYCAEMIC AGENT
#8533METHOD AND MEDICINE FOR TREATING HUNTINGTON'S DISEASE
#8534Collagen peptide-based medicament compositions and devices and methods of production and use thereof
#8535DIFFERENT FORMS OF 6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE
#8536Use of Immune Suppressive Domains as Medicaments
#8537Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms
#8538CARDIOSPHERE-DERIVED CELL (CDC) THERAPY FOR THE TREATMENT OF VIRAL INFECTIONS
#8539Method for treating HIV/AIDS complications such as viral encephalopathy, drug-induced encephalopathy, and neurological disorders of immunocompromised concurrent opportunistic infections including motor nerve, sensory nerve and optic nerve disorders
#8540FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
#8541Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
#8542COMPOSITION AND METHODS FOR IMPROVING HEART FUNCTION AND TREATING HEART FAILURE
#85431H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
#8544TARGETING ALPHA3BETA1 INTEGRIN FOR TREATMENT OF CANCER AND OTHER DISEASES
#8545SIRP-GAMMA TARGETED AGENTS FOR USE IN THE TREATMENT OF CANCER
#8546ANTIMALARIAL AGENTS
#8547FORMULATIONS OF TIE-2 ACTIVATORS AND METHODS OF USE THEREOF
#8548Methods of treating gastrointestinal diseases characterized by inflammatory cells
#8549COMPOUNDS AND USES THEREOF
#8550METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REPROGRAMING IMMUNE ENVIRONMENT IN A SUBJECT IN NEED THEREOF
#8551ORAL PRODUCT WITH A BASIC AMINE AND AN ION PAIRING AGENT
#8552RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS
#8553ANTI-CLAUDIN-1 MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF FIBROTIC DISEASES
#8554CYANO-PYRIMIDINE INHIBITORS OF EGFR/HER2
#8555INTERFERON TAU AS ANTIVIRAL THERAPY
#8556USE OF A COMPOUND OF THE DIURETICS CLASS FOR TREATING CANCER
#8557MESENCHYMAL STEM CELLS FOR THE PREVENTION AND TARGETED TREATMENT OF CANCER AND OTHER DISORDERS
#8558METHOD FOR PRODUCING POLYMERSOMES
#85596-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING DISEASES AND CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY
#8560Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent
#8561Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels
#8562PEPTIDES AND USES THEREOF
#8563METHODS FOR TREATING HYPERCHOLESTEROLEMIA
#8564METHODS AND COMPOSITIONS FOR ENHANCING ACTIVITY OF T CELLS WITH MODIFIED B CELLS
#8565COMPOSITIONS AND METHODS FOR SILENCING VEGF-A EXPRESSION
#8566PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASE CONTAINING AKKERMANSIA MUCINIPHILA STRAIN
#8567Non-adult human dosing of anti-CD30 antibody-drug conjugates for treatment of hematological or lymphoid cancer
#8568Materials and methods for inhibiting a viral infection, including a coronavirus infection
#8569METHODS AND COMPOSITIONS FOR TREATING ACUTE MYELOID LEUKEMIA
#8570AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF
#8571Treatment for hot flushes
#8572ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF
#8573Nebulization formulations for delivery to lower respiratory tract
#8574BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF
#8575METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
#8576COMPOUNDS AS CDK2/4/6 INHIBITORS
#8577FGFR TYROSINE KINASE INHIBITORS AND ANTI-PDI AGENTS FOR THE TREATMENT OF UROTHELIAL CARCINOMA
#8578GLUCOSE TRIPTOLIDE CONJUGATES AND USES THEREOF
#8579TOPICAL DELIVERY OF BUFFERING AGENTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
#8580BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT
#8581TREATMENT OF STEM CELL DEFICIENCY
#8582METHODS OF SYNTHESIZING CAROTENOIDS
#8583Tamper resistant dosage forms
#8584METHODS OF TREATING CANCER WITH INTERFERON WHEREIN THE CANCER CELLS ARE HLA NEGATIVE OR HAVE REDUCED HLA EXPRESSION
#8585SUBLINGUAL CANNABINOID COMPOSITIONS
#8586COMPOUNDS FOR METHODS FOR PROMOTING FEMALE REPRODUCTIVE HEALTH THROUGH MEDIATION OF RENIN ANGIOTENSIN FUNCTION
#8587METHODS OF TREATING GLIOBLASTOMA
#8588Anti-TIGIT Antibodies
#8589CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF
#8590METHODS OF TREATING VIRAL INFECTIONS AND HEALTH CONSEQUENCES
#8591MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#8592LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#8593SETD2 INHIBITORS AND RELATED METHODS AND USES, INCLUDING COMBINATION THERAPIES
#8594MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#8595COMPOSITIONS AND METHODS FOR TREATING CANCER
#8596Compositions and methods for cancer therapy
#8597THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS
#8598EXTENDED RELEASE GASTRORETENTIVE FORMULATION AGAINST HELICOBACTER PYLORI
#8599USE OF PYRIDO[1,2-A]PYRIMIDINONE COMPOUND IN TREATING LYMPHOMA
#8600DIHYDRO-SPIRO[INDOLINE-3:1'-iSOQUINOLIN]-2-ONES AS ANTIMALARIAL AGENTS
#8601TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS
#8602Composition including rilpivirine and method for treating tumors or cancer
#8603PROLIFERATION SUPPRESSING AGENT FOR CANINE CANCER CELLS
#8604FABS-IN-TANDEM IMMUNOGLOBULIN AND USES THEREOF
#8605USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
#8606COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND THE USE THEREOF
#8607COMBINATION THERAPY
#8608Methods and compositions for the treatment of C. difficile
#8609PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING EPIDEMIC RNA VIRAL INFECTIOUS DISEASE
#8610DEGRADATION OF PROTEIN KINASES BY CONJUGATION OF PROTEIN KINASE INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE
#8611QUINOLINE COMPOUNDS FOR TREATING RESPIRATORY DISORDERS AND VIRAL INFECTIONS
#8612BACTERIUM OF THE CHRISTENSENELLACEAE FAMILY AND COMPOSITION CONTAINING SAME FOR THE PREVENTION AND/OR TREATMENT OF PATHOLOGICAL MUSCLE LOSS OR OF A DISEASE CHARACTERISED BY PATHOLOGICAL MUSCLE LOSS
#8613FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE
#8614CD73 inhibitors
#8615[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS
#8616Natural preservatives and antimicrobial agents, including compositions thereof
#86173-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament
#8618Method of treating cancer using selective estrogen receptor modulators
#86191H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
#8620HUMAN ORIGIN PROBIOTIC LACTOBACILIUS RHAMNOSUS HL-200 TO REDUCE LEAKY GUT BY METABOLIZING ETHANOLAMINE
#8621Oncolytic virus strain
#8622METHODS TO PREVENT, AMELIORATE AND TREAT COMPLICATIONS FROM VIRAL INFECTIONS
#8623GLYCOLIPID COMPOSITIONS AND METHODS OF USE
#8624MONO AND COMBINATION THERAPIES WITH ULK1/2 INHIBITORS
#8625METHODS OF TREATING MIGRAINE
#8626ENHANCED EFFICACY OF COMBINATION OF GEMCITABINE AND PHOSPHATIDYLSERINE-TARGETED NANOVESICLES AGAINST PANCREATIC CANCER
#8627DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS
#8628Combination therapies and patient stratification with bispecific anti-EGFR/c-Met antibodies
#8629METHODS OF TREATMENT WITH S1P RECEPTOR MODULATORS
#8630PHARMACEUTICAL COMBINATION AND USE THEREOF
#8631MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY
#8632Compositions useful for treating disorders related to KIT
#8633COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC DISEASE
#8634METHODS OF IMPROVING RENAL FUNCTION
#8635SMALL MOLECULE BCL-2 FUNCTIONAL CONVERTERS AS CANCER THERAPEUTICS
#8636Compositions And Methods For Treating Attention Deficit Disorders
#8637METHODS TO PREVENT SARS-COV-2 INFECTION AND TREAT COVID-19
#8638METHODS AND PHARMACEUTICAL COMPOSITIONS OF THROMBOXANE A2 RECEPTOR ANTAGONIST FOR THE TREATMENT OF COVID-19
#8639METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE
#8640COMPOSITIONS AND METHODS FOR THE TREATMENT OF BONE AND JOINT DISEASES
#8641COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELIN RELATED AND INFLAMMATION RELATED DISEASES OR DISORDERS
#8642TREATMENT OF DISEASE WITH ESTERS OF SELECTIVE RXR AGONISTS
#8643MULTI CHAMBER SYRINGE UNIT AND METHOD OF PREPARING A MULTI CHAMBER SYRINGE
#8644Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
#864517α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors
#8646GOLD-CONTAINING AGENTS FOR THE TREATMENT OF LUNG INFECTIONS
#8647SYK KINASE INHIBITORS AS TREATMENT FOR MALARIA
#8648METHOD FOR TREATING CANCER
#8649MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF
#8650AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#8651Early Drug Interventions to Reduce COVID-19 Related Respiratory Distress, Need for Respirator Assist and Death
#8652HEPATITIS B CAPSID ASSEMBLY MODULATORS
#8653AD7-VECTORED VACCINE FOR PREVENTING SARS- COV-2 INFECTION
#8654METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#8655NEUROPROTECTIVE PEPTIDE
#8656ANTIBODY-CONJUGATES WITH IMPROVED THERAPEUTIC INDEX FOR TARGETING HER2 TUMOURS AND METHOD FOR IMPROVING THERAPEUTIC INDEX OF ANTIBODY-CONJUGATES
#8657MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#8658Compounds for treating ILK-mediated diseases
#8659PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS
#8660SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF
#8661MUSCLE REGENERATION
#8662STRUCTURE OF ONCOLYTIC VIRUS COMPRISING BISPECIFIC NUCLEIC ACID MOLECULE
#8663ANTIBODIES AGAINST PD-L1 AND METHODS OF USE THEREOF
#8664METHODS FOR TREATING CYTOKINE STORM SYNDROME AND RELATED DISEASES
#8665MEDICAMENT AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS INVOLVING BIOFILM
#8666TREATMENT OF DISEASE WITH ESTERS OF SELECTIVE RXR AGONISTS
#8667METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME
#8668OCULAR DRUG DEPOT FOR COMPLEMENT-MEDIATED DISORDERS
#8669COMPOSITIONS FOR CORONAVIRUS INFECTION TREATMENT AND/OR PREVENTION
#8670[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS
#8671HETEROCYCLIC INHIBITORS OF RHO GTPases FOR THE TREATMENT OF DISEASE
#8672METHOD OF TREATING MICROBIAL INFECTIONS
#8673METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS
#8674SYNTHESIS OF NOVEL EP4 ANTAGONIST AND USE IN CANCER AND INFLAMMATION
#8675Methods of measuring signaling pathway activity for selection of therapeutic agents
#8676BIOMARKERS FOR PREDICTING RESPONSE TO IL-6 ANTAGONIST IN COVID-19 PNEUMONIA
#8677ORONASAL CBD FORMULATIONS AND USES THEREOF
#8678COMPOSITIONS AND METHODS FOR THE TREATMENT OF SANFILIPPO DISEASE AND OTHER DISORDERS
#8679BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATING MICROBIAL CO-INFECTIONS
#8680GLS1 inhibitors for treating disease
#8681Multi-targeted tyrosine kinase inhibitors and their pharmaceutical uses
#8682COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRAS
#8683AGENTS AND COMPOSITIONS FOR THE TREATMENT OF GLIOBLASTOMA
#8684QTY Fc fusion receptor proteins
#8685Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
#8686COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS
#8687USE OF CONJUGATES COMPRISING TUMOUR-SELECTIVE LIGANDS AND GROUPS CAPABLE OF RELEASING CARBON MONOXIDE (CO), FOR EXERTING IMMUNOMODULATORY EFFECTS IN CANCER TREATMENT
#8688MODULATION OF IMMUNE CELLS
#8689Multi-targeted tyrosine kinase inhibitors effective in antitumor uses
#8690GLYCAN COMPOSITIONS AND METHODS OF USE
#8691COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL
#8692METHODS OF SLOWING BRAIN VOLUME LOSS
#8693COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CANCER USING DEUBIQUITINASE INHIBITORS
#8694Crystalline 5-methoxy-n,n-diallyltryptamine compounds
#8695ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#8696METHODS AND COMPOSITIONS FOR TREATMENT OF ATHEROSCLEROSIS
#8697HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE
#8698DEXTROSE TABLETS WITH IMPROVED MOUTHFEEL
#8699METHOD FOR OBTAINING A BOTANICAL EXTRACT
#8700Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment